Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.

Oni C, Mitchell S, James K, Ng WF, Griffiths B, Hindmarsh V, Price E, Pease CT, Emery P, Lanyon P, Jones A, Bombardieri M, Sutcliffe N, Pitzalis C, Hunter J, Gupta M, McLaren J, Cooper A, Regan M, Giles I, Isenberg D, Saravanan V, Coady D, Dasgupta B, McHugh N, Young-Min S, Moots R, Gendi N, Akil M, Barone F, Fisher B, Rauz S, Richards A, Bowman SJ

Open source

DOI
10.1093/rheumatology/kex331
Published
2017 Dec 1
Container
Rheumatology (Oxford, England)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/rheumatology/kex331,
  title = {Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.},
  author = {Oni C and Mitchell S and James K and Ng WF and Griffiths B and Hindmarsh V and Price E and Pease CT and Emery P and Lanyon P and Jones A and Bombardieri M and Sutcliffe N and Pitzalis C and Hunter J and Gupta M and McLaren J and Cooper A and Regan M and Giles I and Isenberg D and Saravanan V and Coady D and Dasgupta B and McHugh N and Young-Min S and Moots R and Gendi N and Akil M and Barone F and Fisher B and Rauz S and Richards A and Bowman SJ},
  year = {2017},
  journal = {Rheumatology (Oxford, England)},
  doi = {10.1093/rheumatology/kex331},
  url = {https://doi.org/10.1093/rheumatology/kex331}
}

RIS

TY  - JOUR
TI  - Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.
AU  - Oni C
AU  - Mitchell S
AU  - James K
AU  - Ng WF
AU  - Griffiths B
AU  - Hindmarsh V
AU  - Price E
AU  - Pease CT
AU  - Emery P
AU  - Lanyon P
AU  - Jones A
AU  - Bombardieri M
AU  - Sutcliffe N
AU  - Pitzalis C
AU  - Hunter J
AU  - Gupta M
AU  - McLaren J
AU  - Cooper A
AU  - Regan M
AU  - Giles I
AU  - Isenberg D
AU  - Saravanan V
AU  - Coady D
AU  - Dasgupta B
AU  - McHugh N
AU  - Young-Min S
AU  - Moots R
AU  - Gendi N
AU  - Akil M
AU  - Barone F
AU  - Fisher B
AU  - Rauz S
AU  - Richards A
AU  - Bowman SJ
PY  - 2017
JO  - Rheumatology (Oxford, England)
DO  - 10.1093/rheumatology/kex331
UR  - https://doi.org/10.1093/rheumatology/kex331
ER  - 

APA

C, O., S, M., K, J., WF, N., B, G., V, H., E, P., CT, P., P, E., P, L., A, J., M, B., N, S., C, P., J, H., M, G., J, M., A, C., M, R., I, G., D, I., V, S., D, C., B, D., N, M., S, Y., R, M., N, G., M, A., F, B., B, F., S, R., A, R., & SJ, B. (2017). Eligibility for clinical trials in primary Sjögren's syndrome: lessons from the UK Primary Sjögren's Syndrome Registry.. Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/kex331

Source records